STUDY OBJECTIVES: To screen the PER3 promoter for polymorphisms and investigate the phenotypic associations of these polymorphisms with diurnal preference, delayed sleep phase disorder/syndrome (DSPD/DSPS), and their effects on reporter gene expression. DESIGN: Interspecific comparison was used to define the approximate extent of the PER3 promoter as the region between the transcriptional start site and nucleotide position -874. This region was screened in DNA pools using PCR and direct sequencing, which was also used to screen DNA from individual participants. The different promoter alleles were cloned into a luciferase expression vector and a deletion library created. Promoter activation was measured by chemiluminescence. SETTING: N/A. PATIENTS OR PARTICIPANTS: DNA samples were obtained from volunteers with defined diurnal preference (3 x 80, selected from a pool of 1,590), and DSPD patients (n=23). INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS: We verified three single nucleotide polymorphisms (G -320T, C -319A, G -294A), and found a novel variable number tandem repeat (VNTR) polymorphism (-318 1/2 VNTR). The -320T and -319A alleles occurred more frequently in DSPD compared to morning (P = 0.042 for each) or evening types (P = 0.006 and 0.033). The allele combination TA2G was more prevalent in DSPD compared to morning (P 0.033) or evening types (P = 0.002). Luciferase expression driven by the TA2G combination was greater than for the more common GC2A (P < 0.05) and the rarer TA1G (P < 0.001) combinations. Deletion reporter constructs identified two enhancer regions (-703 to -605, and -283 to -80). CONCLUSIONS: Polymorphisms in the PER3 promoter could affect its expression, leading to potential differences in the observed functions of PER3.
STUDY OBJECTIVES: To screen the PER3 promoter for polymorphisms and investigate the phenotypic associations of these polymorphisms with diurnal preference, delayed sleep phase disorder/syndrome (DSPD/DSPS), and their effects on reporter gene expression. DESIGN: Interspecific comparison was used to define the approximate extent of the PER3 promoter as the region between the transcriptional start site and nucleotide position -874. This region was screened in DNA pools using PCR and direct sequencing, which was also used to screen DNA from individual participants. The different promoter alleles were cloned into a luciferase expression vector and a deletion library created. Promoter activation was measured by chemiluminescence. SETTING: N/A. PATIENTS OR PARTICIPANTS: DNA samples were obtained from volunteers with defined diurnal preference (3 x 80, selected from a pool of 1,590), and DSPDpatients (n=23). INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS: We verified three single nucleotide polymorphisms (G -320T, C -319A, G -294A), and found a novel variable number tandem repeat (VNTR) polymorphism (-318 1/2 VNTR). The -320T and -319A alleles occurred more frequently in DSPD compared to morning (P = 0.042 for each) or evening types (P = 0.006 and 0.033). The allele combination TA2G was more prevalent in DSPD compared to morning (P 0.033) or evening types (P = 0.002). Luciferase expression driven by the TA2G combination was greater than for the more common GC2A (P < 0.05) and the rarer TA1G (P < 0.001) combinations. Deletion reporter constructs identified two enhancer regions (-703 to -605, and -283 to -80). CONCLUSIONS: Polymorphisms in the PER3 promoter could affect its expression, leading to potential differences in the observed functions of PER3.
Authors: Ying Xu; Quasar S Padiath; Robert E Shapiro; Christopher R Jones; Susan C Wu; Noriko Saigoh; Kazumasa Saigoh; Louis J Ptácek; Ying-Hui Fu Journal: Nature Date: 2005-03-31 Impact factor: 49.962
Authors: C R Jones; S S Campbell; S E Zone; F Cooper; A DeSano; P J Murphy; B Jones; L Czajkowski; L J Ptácek Journal: Nat Med Date: 1999-09 Impact factor: 53.440
Authors: Indrani Halder; Karen A Matthews; Daniel J Buysse; Patrick J Strollo; Victoria Causer; Steven E Reis; Martica H Hall Journal: Sleep Date: 2015-08-01 Impact factor: 5.849
Authors: Hader A Mansour; Joel Wood; Kodavali V Chowdari; Divya Tumuluru; Mikhil Bamne; Timothy H Monk; Martica H Hall; Daniel J Buysse; Vishwajit L Nimgaonkar Journal: Chronobiol Int Date: 2017-02-27 Impact factor: 2.877
Authors: Heon-Jeong Lee; Katharine M Rex; Caroline M Nievergelt; John R Kelsoe; Daniel F Kripke Journal: J Affect Disord Date: 2011-05-20 Impact factor: 4.839
Authors: Fatemeh Haghighi; Yongchao Ge; Sean Chen; Yurong Xin; Michelle U Umali; Rita De Gasperi; Miguel A Gama Sosa; Stephen T Ahlers; Gregory A Elder Journal: J Neurotrauma Date: 2015-05-07 Impact factor: 5.269